Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV-1-Infected Patients Starting Efavirenz, Lopinavir-Ritonavir, or Atazanavir-Ritonavir Plus Tenofovir/Emtricitabine: Final 48-Week Results (The Advanz-3 Trial).
| Image |  |
|---|---|
| Description | scientific article published on June 2015 |
| Author/s |
author: Daniel Podzamczer Adrian Curran Bonaventura Clotet Sala Felipe García Francisco Lozano |
| Publication date | June 1, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |